🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

INFU INFU

Company Profile ↓
$12.15
+107.69% 1Y
P/E39.19
52W High$12.32
52W Low$5.85
EPS (TTM)$0.31

Company Overview

INFU (INFU) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 14.4% per year over the last five years.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $143.44M (+6.4% YoY); net profit $6.63M.
  • Trailing 12 Months Year-on-year growth — revenue +6.4%, earnings +182.6%.
  • 5-Year Trend Long-term compounding — revenue CAGR 8.5%, profit CAGR 14.4%.

Growth & Price Performance

Compounded Sales Growth

5 Years:8.49%
1 Year:6.36%

Compounded Profit Growth

5 Years:14.36%
1 Year:182.60%

Stock Price Performance

1 Year:+107.69%
6 Months:+46.56%
3 Months:+14.41%
1 Month:+25.39%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 97% of range
$5.85 $12.32
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • Golden Cross8d ago
  • RSI (14)72.88 · Overbought
Price Performance
1M+25.39%
3M+14.41%
6M+46.56%
1Y+107.69%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Profit CAGR of 14.4% over 5 years.
  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
39.19
Industry PE
-
Forward P/E est.
19.59
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
8.49%
Profit 5Y
14.36%
Revenue (YoY)
6.36%
Earnings (YoY)
182.60%

Profitability & Returns

ROCE
14.83%
ROE
11.56%
ROA
6.59%
Profit Margin
4.62%
Op Margin
8.31%
Gross Margin
55.98%
EPS (Latest Qtr)
$0.05
EPS (TTM)
$0.31

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$98.66M
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
7.15%
Chg in Prom Hold
-
FII / Inst Holding
79.71%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$143.44M
EBITDA
-
Free Cash Flow
$23.85M
Operating Cash Flow
$24.41M
Shares Outstanding
-
Gross Margin
55.98%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2013Jun 2013Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Mar 2026
Revenue ------------17.65M16.94M17.59M16.48M16.41M16.68M18.19M19.72M21.49M21.55M26.00M25.12M24.46M24.83M26.57M26.76M27.04M27.28M30.37M31.73M31.91M32.00M33.70M35.32M34.72M36.00M36.49M33.68M
Gross Profit 10.42M10.33M11.34M12.08M11.92M11.73M12.09M11.85M12.88M12.56M11.14M10.39M10.65M10.34M11.04M10.24M9.69M9.67M10.34M11.36M12.24M12.66M15.98M15.12M14.58M15.05M15.26M15.37M14.90M16.22M14.95M15.83M15.62M16.47M16.67M19.05M19.17M19.87M20.82M19.68M
Operating Income 652.00K861.00K1.92M1.78M2.34M2.44M1.55M1.32M2.33M414.00K438.00K576.00K-1.97M-1.09M560.00K588.00K-204.00K-95.00K-420.00K971.00K1.66M33.00K4.51M3.25M873.00K696.00K-351.00K-525.00K207.00K943.00K-107.00K1.25M1.70M-845.00K1.85M3.27M618.00K3.78M3.81M1.59M
Net Income 51.00K105.00K649.00K583.00K886.00K852.00K-415.00K783.00K1.14M41.00K153.00K56.00K-1.48M-1.11M-129.00K204.00K-505.00K-519.00K-960.00K381.00K1.14M-418.00K4.14M2.94M661.00K820.00K-448.00K-368.00K-164.00K443.00K-324.00K435.00K689.00K-1.11M717.00K1.81M-267.00K2.60M2.26M1.02M
Diluted EPS 0.000.000.030.030.040.04-0.020.030.050.000.010.00-0.07-0.05-0.010.01-0.02-0.03-0.050.020.05-0.020.190.140.030.04-0.02-0.02-0.010.02-0.020.020.03-0.050.030.08-0.010.120.110.05

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 38.96M47.23M54.64M58.83M62.28M66.49M70.54M70.50M71.08M67.14M81.11M97.39M102.38M109.91M125.78M134.86M143.44M
Gross Profit 28.64M33.55M35.35M42.91M43.68M47.35M49.60M44.74M43.36M39.57M46.88M58.76M58.54M60.56M63.11M70.40M80.30M
Operating Income 5.33M-938.00K-66.36M2.00M5.90M9.33M7.28M974.00K-3.81M415.00K3.52M8.83M2.82M1.65M4.09M6.89M11.92M
Net Income 774.00K-1.85M-45.44M-1.49M1.67M3.36M2.79M-222.00K-20.71M-1.09M1.36M17.33M1.42M18.00K872.00K2.35M6.63M
Diluted EPS 0.04-0.09-2.16-0.070.080.150.12-0.01-0.91-0.050.070.800.060.000.040.110.31

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --130.36M76.26M77.52M77.37M80.21M95.36M96.34M68.88M64.07M79.22M96.99M97.59M99.39M102.92M103.61M100.56M
Total Equity 80.07M81.47M85.14M40.16M40.01M42.72M46.45M50.32M50.69M30.95M20.44M22.33M40.75M48.27M48.00M52.30M57.53M57.33M
Cash & Equivalents 11.51M7.75M5.01M799.00K2.33M1.14M515.00K818.00K3.40M3.47M4.32M2.65M9.65M186.00K165.00K231.00K527.00K3.19M
Long Term Debt --26.65M22.55M27.32M21.61M19.03M26.55M26.58M25.35M28.84M30.30M29.38M32.75M33.16M29.10M23.86M19.62M
Total Liabilities --45.22M36.10M37.51M34.65M33.76M45.04M45.66M37.93M43.63M56.89M56.24M49.31M51.38M50.61M46.09M43.23M
Current Liabilities --12.38M13.13M10.20M13.04M14.73M15.26M16.44M12.47M14.79M21.85M23.00M12.90M14.47M15.71M17.66M20.18M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 9.71M10.81M6.75M5.45M7.46M--7.91M7.72M11.39M13.88M20.28M18.32M17.52M11.22M20.46M24.41M
Investing Cash Flow -4.61M-19.06M-5.13M-2.56M-2.16M---5.34M918.00K-4.98M-19.64M-12.16M-21.32M-11.48M-6.73M-13.24M-6.79M
Financing Cash Flow -8.86M5.51M-5.83M-1.37M-6.49M--15.00K-8.56M-5.56M4.10M-1.12M-6.46M-6.06M-4.42M-6.92M-14.96M
Capital Expenditure -----4.72M-2.00M-314.00K-168.00K-104.00K-281.00K-2.93M-1.09M-980.00K-982.00K-1.02M-1.09M-560.00K
Free Cash Flow ----2.74M--7.74M7.61M11.11M10.95M19.19M17.34M16.54M10.20M19.37M23.85M
Share Buybacks -68.00K363.00K144.00K79.00K204.00K179.00K75.00K-10.39M00560.00K5.46M153.00K1.18M9.87M

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 73.5%71.0%64.7%72.9%70.1%71.2%70.3%63.5%61.0%58.9%57.8%60.3%57.2%55.1%50.2%52.2%56.0%
Operating Margin % 13.7%-2.0%-121.4%3.4%9.5%14.0%10.3%1.4%-5.4%0.6%4.3%9.1%2.8%1.5%3.2%5.1%8.3%
Net Margin % 2.0%-3.9%-83.2%-2.5%2.7%5.0%3.9%-0.3%-29.1%-1.6%1.7%17.8%1.4%0.0%0.7%1.7%4.6%
ROE % 1.0%-2.2%-113.1%-3.7%3.9%7.2%5.5%-0.4%-66.9%-5.4%6.1%42.5%2.9%0.0%1.7%4.1%11.6%
ROCE % --0.8%-105.1%3.0%9.2%14.2%9.1%1.2%-6.8%0.8%6.1%11.9%3.3%1.9%4.7%8.0%14.8%

Shareholding Pattern

Insiders
7.15%
Institutions
79.71%
Public Float
85.85%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for INFU

Google News Wed, 05 Aug 2026

InfuSystem (INFU) Stock Jumps As Margin Gains Reset The Narrative - simplywall.st

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUklheEZvU1hZOFVjWWlkOGRaSjdHQnJyQWZjUTVpdm1GeUt4Q0g5SEg0cjRtb2NhcExVYnQ2anlrTUVBVmNxdGJZN2lKNDVWM1F3X2tsN0lUM0swWnhLR0IxRXZadHN2VmRXcWVxcHhELVJ1UUF1aF9hNGdNX3R3bWtnd2RjV1BpVUgyUH…

Google News ue, 04 Aug 2026

$INFU stock is up 16% today. Here's what we see in our data. - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxPS2Y0bXhfc3lqdVdDRDYwcjhSdl90dVJHaTNpMjhfazBhek9MMDg4Nk5udE9ERnNvRzVnWHF3N2VORTdhclpySF85X2w1UF9hYjNvcHoyRzVGck9SWEdiWUNxZVlvTF9rS2MxUGlPM3NNNVdjN2NJeUZYbjlwSjBlQmhTenhPYXhGdVRvaE…

Google News ue, 04 Aug 2026

InfuSystem Wound Care Revenue Rises 154% in Second Quarter - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPT0hidnRFeDNCbGtsU19sYlFwZFlvcm5PMGJ1VXBOcV9RVTVmeF9uZEx1c0hUM2NLSGU0a3Z5ME9GRmJaa0k4U0JPeTE0Rk8tMWJxbjR5UlFoREZSUFFWbmNJZ2htYmYyNG91LXNpbGpNT0FXVzItcmZsdG1xOFhoS2x4YWRWTnJPaXRwRE…

Google News ue, 04 Aug 2026

InfuSystems Holdings, Inc. (INFU) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance UK

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYlc1MVN4emxCMjJvWi1lVVJtdEw5cUJ3V01sajNyWUpBV3h5V0hJQ1lLOHdrS05pTG1hRFJXTnJudmVYQWVkTEtGcmVQc1dtUFJ1dmF0cVBnakdaLWdBbjh0dW9ac2Z6VFl4OG8tZDFHRWZmNVBEMGNJZzBhanFIa1g2OXdENTY5?oc=5"…

Google News ue, 04 Aug 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPMmNLajVqdmNLUURTZkx2bDVoN0s2ajJpQ2tsVFF1N05YVUNyS1VFTi1NZkNkb24xT3BiQnZWNWhVU25tdUlWUGtSeWlOSHVzUVVvQW4xeTFCa3EzcWZNMEdVZnZ5NjRDa2toQmVfTzNxX2xPYzlXTmlqeEUzYTZZQjNBc3lpRE1QejBXTm…

Google News ue, 04 Aug 2026

INFU Looks 2.5% Undervalued on GF Value™ - GuruFocus

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxQaEN5V2JjVG5OS2hkQTFUS1BfRVpqbzZTZ1dHbVhleVJnOG9aUDdPZlZyLVZrOGtXa2tzOTc2OV9BcFhWSGJHOHJ1dGRYaTFONEFYRjlxcVJxaGhybS03V01PVWtxVzdxQk5EWFlueEdPNEJNX2hkbThHZHBsNmhwZE53?oc=5" target=…

INFU — Frequently Asked Questions

What is the current share price of INFU?

As of 2026-08-05 17:25 PDT, INFU trades at $12.15 on NASDAQ/NYSE. Its 52-week range is $5.85 to $12.32.

What is the P/E ratio of INFU?

INFU trades at a trailing price-to-earnings (P/E) ratio of 39.19.

What is the return on equity (ROE) of INFU?

INFU has a return on equity (ROE) of 11.56%. Its return on capital employed (ROCE) is 14.83%.

Is INFU a good stock to buy?

This page provides a data-driven analysis of INFU, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space